The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 No. 775

PART 12 U.K. Amendment of Part 12 (dealings with medicinal products)

Amendment of regulation 230 (exemption for supply etc under a PGD to assist doctors or dentists) U.K.

[F1 188.   For regulation 230(8) substitute—

“(8) Condition G is that when the product is supplied or (as the case may be) administered —

(a) in Northern Ireland, a UKMA(NI), UKMA(UK), EU marketing authorisation, Article 126a authorisation, certificate of registration, THR(NI) or THR(UK), or

(b) in Great Britain, a UKMA(GB), UKMA(UK), certificate of registration, THR(GB) or THR(UK),

is in force in relation to it.”.]

Textual Amendments

F1 Reg. 188 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 142

Commencement Information

I1 Reg. 188 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1